Figure 1.
Participant Flow.
Table 1.
Basic demographic and behavioural characteristics of study population (n = 450:150 participants per arm).
Table 2.
Concurrent medications and self-reported adherence to trial medication (n = 408).
Table 3.
Interim antibiotic use and self-reported side effects to trial medications (n = 408).
Table 4.
Recurrence Rates and Relative Risk of Recurrence of BV and of Abnormal flora at Month one and Month six by Treatment Group (n = 408)†.
Figure 2.
Probability of being free from BV recurrence over 6 months.
Figure 3.
Probability of being free from abnormal flora recurrence over 6 months.